Chris Buyse, Chief Financial Officer and Board Member of ThromboGenics NV, will resign effective June 30, 2014. As of July 1, 2014 Luc Philips, former CFO of KBC group and Board Member of ThromboGenics since its IPO, will take on the role of interim-CFO until the Company completes an international search for a new permanent CFO.